A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Clinical trial NCT06422923 · RECRUITING

Trial details

NCT number: NCT06422923
Sponsor: Neurona Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epilepsy, Temporal Lobe

Start date: 2024-11-14
Primary completion: 2027-06-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.